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Plymouth, United KingdomTABLE 1. Patient characteristics
Patient no.Cardiac surgery in Jehovah’s Witnesses often poses a chal-
lenge to the surgeon because these patients refuse transfusion
of the primary components of blood (red cells, white cells,
plasma, and platelets), although individual believers can
decide for themselves to accept processed fractions of the
primary components. Most cardiac surgeons around the
world use standard cardiopulmonary bypass circuits for
coronary artery bypass grafting in these patients. Minimal
extracorporeal circulation (MECC) is a fully heparin-coated
closed-loop cardiopulmonary bypass system. It excludes the
blood–gas interface and has active venous drainage, a centrif-
ugal pump, membrane oxygenator, and a priming volume of
800 mL, reduced further to around 300 mL by the use of
retrograde priming of the circuit.1 2 3 4 5 6 7
Age (y) 65 71 71 50 64 50 72
Sex M M M M M M F
Hypertension No Yes Yes Yes No Yes No
LV function Good Good Poor Good Good Good Good
Surgery CABG CABG CABG CABG CABG CABG AVR
No. of grafts 3 3 3 2 3 2 None
Preop Hb (g/dL) 14.8 14 9.7 13.9 15.6 15.6 14.2
Crossclamp (min) 30 34 36 23 27 25 37CLINICAL SUMMARY
Between May 2007 and February 2009, 7 Jehovah Wit-
ness patients underwent cardiac surgery using this technique
(coronary artery bypass grafting in 6 and aortic valve
replacement in 1). There were 6 male patients and 1 female
patient with an average age of 63 years. Comorbidites
included hypertension, and 1 patient had poor left ventricu-
lar function (Table I).Average preoperative hemoglobin level was 14  2.01
g/dL; postoperative hemoglobin level 10.35  1.32 g/dL
and percentage drop of hemoglobin on day 1 was 25% 
9.04%. Average bypass time was 53  8.57 minutes.DISCUSSION
Standard cardiopulmonary bypass circuits are associated
with marked hemodilution in addition to initiation of the in-
flammatory response because of contact between blood and
artificial surfaces on the lines and oxygenator and also at theBypass time (min) 51 62 57 36 60 52 52
Postop Hb (g/dL) 12.2 10.4 8.2 11.7 9.6 10.3 10.1
Drop in Hb (%) 18 26 15 16 38 34 28
Day 4 Hb (g/dL) 14.2 11.4 8.7 11.4 11.3 11.2 10
Total blood loss (mL) 540 470 865 380 420 310 440
Extubation time (h) 2.5 4 2.5 2 2 2 3
ITU stay (d) 1 1 2 2 1 1 1
Length of stay
in hospital (d)
6 7 14 6 6 6 6
LV, Left ventricular; CABG, coronary artery bypass grafting; AVR, aortic valve re-
placement; Hb, hemoglobin; ITU, intensive treatment unit.
gery c June 2010
Brief Clinical Reportsblood–air interface.1 Inasmuch as this response affects coag-
ulation, it probably contributes to the perioperative fall in
hemoglobin.2
The MECC circuit has a very short tubing length with
elimination of the venous reservoir and avoids the conven-
tional cardiotomy suction. As a result, there is a lower prim-
ing volume and reduced hemodilution compared with
conventional cardiopulmonary circuits3 and probably less
initiation of the inflammatory response.
Patients undergoing bypass surgery on MECC systems
have 30-day mortalities comparable with those of patients
treated with conventional bypass circuits.4 Studies have also
repeatedly demonstrated a decreased requirement for blood
transfusions.4 In our patients, the postoperative hemoglobin
concentration remained higher than our standard transfusion
trigger (8.0 g/dL) and was consistent with previous studies4,5
(Table 1). MECC also allows for complete revascularization
on a still heart and bloodless field and inour experience is tech-
nically less demanding than off-pump surgery.
The reduced priming volume of the MECC system results
in less hemodilution and maintains a near normal hematocrit
during the CPB process. This technique contributes signifi-
cantly to the avoidance of blood transfusion in this subgroup
of patients. We have successfully used this technique in our
institution for coronary artery bypass surgery and moreFrom the Vanderbilt Heart & Vascular Institute, Nashville, Tenn
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The Journal of Thoracic and Carrecently for aortic valve surgery, and we consider the
MECC procedure a useful tool in the armamentarium for
Jehovah’s Witnesses undergoing cardiac surgery. As the ev-
idence for the adverse consequences of homologous blood
transfusion mounts, we should consider treating all of our
patients with fully heparin-coated circuits, low priming vol-
umes, and meticulous surgical hemostasis as in our Jehovah
Witness patients.
We are grateful to Gerry Webb for his assistance in the study.
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Surg. 2002;21:840-6.Use of the hybrid operating room for aortic valve replacement in
a patient with anomalous left circumflex arteryRamanan Umakanthan, MD, Zachary E. Brewer, BS, John G. Byrne, MD, and Rashid M. Ahmad, MD,
Nashville, TennPreoperative detection of anomalous coronary artery anat-
omy and clear delineation of its anatomic course are essen-
tial in patients undergoing aortic valve surgery so that the
surgical technique can be modified to avoid coronary vessel
injury. We present the case of aortic valve replacement
(AVR) in a patient who was discovered to have an aberrant
left circumflex artery (LCX) on coronary angiographicanalysis. We present a new surgical approach for AVR in
the setting of an anomalous LCX.CLINICAL SUMMARY
A 51-year-old man with a history of aortic stenosis, pro-
gressively worsening dyspnea, and an abnormal stress test
result was referred to the Vanderbilt Heart Institute for
AVR. Transesophageal echocardiographic analysis had re-
vealed an aortic valve area of 0.75 cm2 and an ejection frac-
tion of 65% to 70%. Preoperative coronary angiographic
analysis revealed no significant atherosclerotic disease but
demonstrated an anomalous LCX that originated from
a separate ostium adjacent to the ostium of the right coronary
artery and coursed behind the aortic annulus. Computed
tomographic angiographic analysis confirmed the retroaortic
course of the LCX.diovascular Surgery c Volume 139, Number 6 e123
